» Articles » PMID: 15920533

RelA Regulates the Survival of Activated Effector CD8 T Cells

Overview
Specialty Cell Biology
Date 2005 May 28
PMID 15920533
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear factor of kappa B (NF-kappaB) transcription factors are critical regulators of T-cell activation and survival. The relative contribution of individual NF-kappaB members to these processes remains elusive. We investigated the role of RelA in the regulation of CD8 T-cell activation. We overexpressed, in mature CD8 T cells, a transactivation domain-deficient RelA molecule (p65TAD). We show that p65TAD forms homo- and heterodimers with p50 that bind kappaB sites and selectively inhibit RelA-dependent transactivation. Expression of p65TAD does not affect initial activation or cell cycle progression but induces the death of activated CD8 T cells in vitro and in vivo. However, the long-term survival of resting effector CD8 T cells seems not to be affected by p65TAD expression. Collectively, our results indicate that RelA is a critical regulator of survival of proliferating CD8 T cells but may be dispensable for the survival of resting effector T cells.

Citing Articles

The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer.

Voisin A, Plaschka M, Perrin-Niquet M, Twardowski J, Boutemine I, Eluard B Front Immunol. 2024; 15:1379777.

PMID: 38504985 PMC: 10948531. DOI: 10.3389/fimmu.2024.1379777.


scDecouple: decoupling cellular response from infected proportion bias in scCRISPR-seq.

Meng Q, Wei L, Ma K, Shi M, Lin X, Ho J Brief Bioinform. 2024; 25(2).

PMID: 38324621 PMC: 10849189. DOI: 10.1093/bib/bbae011.


Translation factor eIF5a is essential for IFNγ production and cell cycle regulation in primary CD8 T lymphocytes.

Tan T, Kelly V, Zou X, Wright D, Ly T, Zamoyska R Nat Commun. 2022; 13(1):7796.

PMID: 36528626 PMC: 9759561. DOI: 10.1038/s41467-022-35252-y.


EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice.

Rehm A, Wirges A, Hoser D, Fischer C, Herda S, Gerlach K JCI Insight. 2022; 7(11).

PMID: 35482418 PMC: 9220939. DOI: 10.1172/jci.insight.155534.


Case report and review of the literature: immune dysregulation in a large familial cohort due to a novel pathogenic RELA variant.

Lecerf K, Koboldt D, Kuehn H, Jayaraman V, Lee K, Mosher T Rheumatology (Oxford). 2022; 62(1):347-359.

PMID: 35412596 PMC: 9960492. DOI: 10.1093/rheumatology/keac227.